Results 101 to 110 of about 1,531 (166)

Seasonal and climatic influence on respiratory infections in children with cystic fibrosis. [PDF]

Sci Rep
Mésinèle J, Ruffin M, Guillot L, Boëlle PY, Corvol H, French CF Modifier Gene Study Investigators.   +5 more
europepmc   +1 more source

Cyclophostin and Cyclipostins analogues counteract macrolide-induced resistance mediated by erm(41) in Mycobacterium abscessus. [PDF]

J Biomed Sci
Sarrazin M, Poncin I, Fourquet P, Audebert S, Camoin L, Denis Y, Santucci P, Spilling CD, Kremer L, Le Moigne V, Herrmann JL, Cavalier JF, Canaan S.   +12 more
europepmc   +1 more source

Genomic diversity in <i>Porphyromonas</i>: evidence of <i>Porphyromonas catoniae</i> commensality in lungs. [PDF]

Microb Genom
Velo-Suarez L, Moalic Y, Guilloux CA, Ame J, Lamoureux C, Gouriou S, Le Berre R, Beauruelle C, Héry-Arnaud G.   +8 more
europepmc   +1 more source

P3MA: A Promising Mycobacteriophage Infecting <i>Mycobacterium abscessus</i>. [PDF]

Antibiotics (Basel)
Broncano-Lavado A, Aguilera-Correa JJ, Roquet-Banères F, Kremer L, Mediero A, Seoane-Blanco M, van Raaij MJ, Pagán I, Esteban J, García-Quintanilla M.   +9 more
europepmc   +1 more source

Use of microbiome analysis as a complementary endpoint in clinical trials. [PDF]

iScience
Velo-Suarez L, Guilloux CA, Le Berre R, Gouriou S, Rault G, Mottier D, Meijer L, Héry-Arnaud G.   +7 more
europepmc   +1 more source

From CFTR to a CF signalling network: a systems biology approach to study Cystic Fibrosis. [PDF]

BMC Genomics
Najm M, Martignetti L, Cornet M, Kelly-Aubert M, Sermet I, Calzone L, Stoven V.   +6 more
europepmc   +1 more source

CFTR mutation is associated with bone differentiation abnormalities in cystic fibrosis. [PDF]

J Cyst Fibros
Dumortier C, Frauenpreis A, Hoarau A, Ryan AL, Gangloff SC, Danopoulos S, Velard F, Al Alam D.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Aérosolthérapie dans la mucoviscidose.

Revue des Maladies Respiratoires, 2008
Introduction La prescription de traitements par voie respiratoire est particulierement seduisante dans la mucoviscidose, malgre un depot pulmonaire tres heterogene et variable. Etat des connaissances Les traitements proposes sont essentiellement ceux ayant pour but d’ameliorer la qualite du mucus (serum sale hypertonique ou RhDNase en nebulisation,
J-C Dubus, S. Ravilly
openaire   +1 more source

Mucoviscidose et grossesse

Anesthésie & Réanimation, 2015
Introduction L’amelioration de la prise en charge de la mucoviscidose allonge l’esperance de vie des patientes. Les grossesses sont donc de plus en plus frequentes et constituent une periode a risque dans l’evolution de la maladie. Patientes et methodes Etude retrospective dans notre maternite de 1998 a 2013.
Iman Dira, Julien Corouge
openaire   +2 more sources

Mucoviscidose et rein

Néphrologie & Thérapeutique, 2009
Patients with cystic fibrosis (CF) show a continuing improvement in their life expectancy thanks to advances in knowledge of this disorder, allowing better multidisciplinary routine monitoring and earlier therapeutic interventions. Likewise, more than of 40% of these patients are adults and CF is no more only a pediatric disease.
Richard Montagnac, Fabienne Sanlaville, Bertrand Soto, Vincent Vuiblet, Francis Schillinger   +4 more
openaire   +1 more source